Voiant's Commitment to Quality Affirmed by FDA Inspection with No Findings Raised

Voiant, a leader in clinical trial imaging solutions, is proud to announce the successful completion of an inspection conducted by the U.S. Food and Drug Administration (FDA). WALTHAM, Mass., April 2, 2024 /PRNewswire-PRWeb/ -- Voiant, a leader in clinical trial imaging solutions, is...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Tags: TRI Source Type: news